Superworth

National Vision price to book ratio EYE

Market value divided by the book value of the company's net assets, since 2017.

Today, Nov 2, 2026
1.5×
9-year median
2.8×
Against its 9-year history
15th
percentile: 0 is its lowest day, 100 its highest
9-year range
0.9× to 12.6×
Peer median
4.2×

National Vision's price to book ratio is 1.5× as of Nov 2, 2026.

That is below its 9-year median of 2.8×, lower than on 85% of days in the last 9 years.

Over that time it ranged from 0.9× in Sep 2024 to 12.6× in Jan 2018.

The median for 10 medical instruments and supplies stocks of a similar size is 4.2×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.5×1.4×2.7×
20252.6×1.0×2.7×
20241.0×0.9×2.2×
20231.9×1.2×3.7×
20223.4×2.2×3.9×
20214.0×3.9×5.7×
20204.2×1.5×4.4×
20193.4×2.3×3.7×
20182.9×2.7×12.6×
201711.9×9.7×11.9×

Against its peers

Companies in Medical - Instruments & Supplies nearest National Vision's size, closest first, today.

CompanyPrice to book ratio
EYENational Vision1.5×
CDRECadre3.9×
STAAStaar Surgical3.4×
BVSBioventus4.8×
IARTIntegra Lifesciences1.0×
IRMDIradimed9.5×
LMATLemaitre Vascular4.4×
INSPInspire Medical Systems2.4×
UFPTUFP Technologies4.8×
MOVMovado1.4×
WRBYWarby Parker7.5×
Peer median4.2×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on National Vision

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.